Search results
Results from the WOW.Com Content Network
The Endo Pharmaceuticals Building, also known as "Endo Laboratories", is a pharmaceutical plant designed by architect Paul Rudolph in 1962 in Garden City, New York, in the receding farmlands of Long Island. The "castle-like structure" was built to house the Endo Pharmaceuticals research, manufacturing and administration facilities.
Endo Pharmaceuticals Holdings was created as a result of a $277 million management buyout of the division from DuPont Merck in 1997, led by Carol Ammon. [6] Through the merger with Algos, it changed name again to Endo Pharmaceuticals Holdings Inc. and began trading as a public company. [9]
NEW YORK (Reuters) -Bankrupt drugmaker Endo International will pay up to $465 million to settle the federal government's law enforcement, tax, and healthcare cost claims, the U.S. Department of ...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
For premium support please call: 800-290-4726 more ways to reach us
From a former name: This is a redirect from a former name or working title of the target topic to the new name that resulted from a name change.